ArticleFrontiers in pharmacology2025

Isoliensinine exerts antitumor effects in lung adenocarcinoma by inhibiting APEX1-driven ROS production.

Cheng Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.